AN EXPLORATORY, RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL, RELATIVE BIOAVAILABILITY STUDY WITH AN ADDITIONAL TWO-PERIOD CROSSOVER FOOD-EFFECT STUDY EXPLORING THE PHARMACOKINETICS OF TWO NOVEL FORMULATIONS OF PEXMETINIB (ARRY-614)
Account has been disabled due to a violation of Terms of Service.